clinical trial matching
Showing 1 - 25 of >10,000
Anterior Teeth Trial (One shade universal composite, Nanohybrid resin composite)
Not yet recruiting
- Anterior Teeth
- One shade universal composite
- Nanohybrid resin composite
- (no location specified)
Dec 17, 2022
Diabetic Kidney Disease Trial in Beijing (SPH3127+SPH3127matching +valsartan matching , SPH3127+valsartan matching , SPH3127
Not yet recruiting
- Diabetic Kidney Disease
- SPH3127+SPH3127matching placebo+valsartan matching placebo
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Jan 9, 2023
Class V Dental Caries Trial (Modified USPHS criteria)
Not yet recruiting
- Class V Dental Caries
- Modified USPHS criteria
- (no location specified)
Jul 16, 2022
Safety and Tolerability Trial in Shanghai (JMKX003142 will be administered orally, Placebo in Cohorts 1 to 7, Placebo in 3
Recruiting
- Safety and Tolerability
- JMKX003142 will be administered orally
- +2 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital, Fudan University
Oct 13, 2023
Postpartum Depression Trial (HS-10353 Capsules 30 mg, Oral, QN for 14 days, HS-10353 Capsules 50 mg, Oral, QN for 14 days,
Not yet recruiting
- Postpartum Depression
- HS-10353 Capsules 30 mg, Oral, QN for 14 days
- +3 more
- (no location specified)
Jul 2, 2023
Coronavirus Disease Trial in Princeton
Completed
- Coronavirus Disease
-
Princeton, New JerseyGlobal Clinical Trials, LLC,
Mar 2, 2023
Rehabilitation, Pneumonia, Viral, COVID-19 Trial in Moscow (exercises, massage)
Completed
- Rehabilitation
- +3 more
- exercises
- massage
-
Moscow, Russian FederationClinical Hospital "MEDSI" in Otradnoe
Apr 11, 2023
NSCLC Trial in Beijing, Tianjin (TQB2450 injection, docetaxel injection matching , AL2846 capsules, TQB2450 matching , docetaxel
Recruiting
- Non-small Cell Lung Cancer
- TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules
- TQB2450 matching placebo, docetaxel injection, AL2846 matching placebo
-
Beijing, Beijing, China
- +2 more
Jun 19, 2023
Diabetes, Type 2 Trial in Changchun (AP026 (TQA2226) for injection, AP026 (TQA2226) for injection matching )
Recruiting
- Diabetes Mellitus, Type 2
- AP026 (TQA2226) for injection
- AP026 (TQA2226) for injection matching placebo
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Nov 16, 2023
Intestinal Health Trial in Chapel Hill ("Humanized" galacto-oligosaccharides (hGOS), Galacto-oligosaccharides (GOS), Matching
Not yet recruiting
- Intestinal Health
- "Humanized" galacto-oligosaccharides (hGOS)
- +2 more
-
Chapel Hill, North CarolinaUNC-Chapel Hill
Sep 28, 2023
Chronic Hepatitis b Trial in Wuhan (TQA3038 injection, TQA3038 injection matching )
Not yet recruiting
- Chronic Hepatitis b
- TQA3038 injection
- TQA3038 injection matching placebo
-
Wuhan, Hubei, ChinaTongji Hospital
Oct 17, 2023
Healthy Volunteer Trial in Leeds (REGN7508 (IV), REGN7508 (SC), Matching Placebo (IV))
Recruiting
- Healthy Volunteer
- REGN7508 (IV)
- +3 more
-
Leeds, United KingdomLabcorp Clinical Research Unit
Jan 30, 2023
Discoloration, Tooth, Chip Tooth, Non Vital Teeth Trial in Cairo (Digital photography combined with eLABor_aid shade analyzing
Recruiting
- Discoloration, Tooth
- +3 more
- Digital photography combined with eLABor_aid shade analyzing software
- +2 more
-
Cairo, EgyptFaculty of dentistry, Cairo University
Mar 7, 2022
Obesity Trial in United States (K-757 and K-833, K-757 and matching to K-833, Matching to K-757 and matching to K-833)
Not yet recruiting
- Obesity
- K-757 and K-833
- +2 more
-
San Diego, California
- +18 more
Aug 25, 2023
Discoloration, Tooth Trial (single-shade universal resin composite (omnichroma) with blocker( omnichroma blocker))
Not yet recruiting
- Discoloration, Tooth
- single-shade universal resin composite (omnichroma) with blocker( omnichroma blocker)
- (no location specified)
Jul 18, 2022
Anemia Trial in Bergen (Calculated red blood cell transfusion, Standard red blood cell transfusion)
Terminated
- Anemia
- Calculated red blood cell transfusion
- Standard red blood cell transfusion
-
Bergen, NorwayHaukeland University Hospital
Aug 24, 2021
Osteoporosis Trial in Shandong (Minodronate Tablets and Alendronate Sodium Tablets-matching ;Alendronate Sodium Tablets and
Not yet recruiting
- Osteoporosis
- Minodronate Tablets and Alendronate Sodium Tablets-matching placebo;Alendronate Sodium Tablets and Minodronate Tablets -matching placebo
-
Shandong, ChinaShandong New Time Pharmaceutical Co., LTD
Mar 22, 2022
Gastroenteritis Trial (Recombinant Norovirus Hexavalent Vaccine, Matching Placebo)
Not yet recruiting
- Gastroenteritis
- Recombinant Norovirus Hexavalent Vaccine
- Matching Placebo
- (no location specified)
Mar 27, 2023
Frailty, Weakness, Muscle, Multiple Chronic Conditions Trial in Chapel Hill (Beta-hydroxymethyl butyrate supplement, Vitamin D
Not yet recruiting
- Frailty
- +2 more
- Beta-hydroxymethyl butyrate supplement
- +2 more
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
May 23, 2023
SCN2A Encephalopathy, SCN8A Encephalopathy Trial in Tacoma (Part A: 0.5mg/kg/day PRAX-562 for 16 Weeks, Part A: 0.5mg/kg/day
Recruiting
- SCN2A Encephalopathy
- SCN8A Encephalopathy
- Part A: 0.5mg/kg/day PRAX-562 for 16 Weeks
- +2 more
-
Tacoma, WashingtonPraxis Research Site
Apr 18, 2023
REM Sleep Behavior Disorder Trial in Camperdown, Oxford (PXS-4728 (A), Matching Placebo (B))
Not yet recruiting
- REM Sleep Behavior Disorder
- PXS-4728 (A)
- Matching Placebo (B)
-
Camperdown, Sydney, Australia
- +1 more
Jun 6, 2023
Pain, Postoperative Trial (Etoricoxib 90 mg, Etoricoxib 120 mg, Ibuprofen 600 mg)
Completed
- Pain, Postoperative
- Etoricoxib 90 mg
- +7 more
- (no location specified)
Feb 7, 2022
Safety Issues Trial in Norfolk, Thika, Durban (TAF/EVG vaginal insert, Matching Placebo vaginal insert)
Not yet recruiting
- Safety Issues
- TAF/EVG vaginal insert
- Matching Placebo vaginal insert
-
Norfolk, Virginia
- +2 more
Oct 11, 2023
Agitation, Dementia Trial in Springfield (BXCL501, Matching Placebo)
Recruiting
- Agitation
- Dementia
- BXCL501
- Matching Placebo
-
Springfield, MassachusettsBioXcel Clinical Research Site
Dec 16, 2022